论文部分内容阅读
脑动脉硬化及血流变学改变是脑卒中的病理基础。合理应用改善血流变性药物有利于预防中风发生。我院静脉用药治疗脑动脉硬化症(CAS)采用单一胞二磷胆碱(CDPC)或 CDPC 与腹蛇抗栓酶交替分疗程静滴,两种治疗方法对临床症状改善均有效果,但血流变学改变却不相同。兹将改变情况报道如下。资料与方法一、临床资料 CDPC 组11例,男5例,女6例,平均年龄60.5岁;CDPC+抗栓酶组20例,男13例,女7例,平均年龄60.25岁。二组病例合乎《脑动脉硬化症的临床诊断标准》。部分病例经头颅 CT 扫描已排除其它脑疾病。两组病例年龄、性别、临床表现均经统计学处理 P>0.05,无显著差异,有可比
Cerebral arteriosclerosis and hemorheology changes are the pathological basis of stroke. Reasonable application of drugs to improve blood rheology is conducive to the prevention of stroke. Intravenous drug treatment of cerebral arteriosclerosis in our hospital (CAS) with a single citicoline (CDPC) or CDPC and abdominal snake antithrombin alternating intravenous infusion of intravenous infusion, the two treatment methods for clinical symptoms have improved, but the blood Rheology changes are not the same. The changes are reported below. Materials and Methods First, clinical data 11 cases of CDPC group, 5 males and 6 females, mean age 60.5 years; CDPC + antithrombin group 20 cases, 13 males and 7 females, average age 60.25 years old. Two groups of patients in line with “clinical diagnosis of cerebral arteriosclerosis criteria.” Some cases of brain CT scan has ruled out other brain diseases. Two groups of patients age, gender, clinical manifestations were statistically processed P> 0.05, no significant difference, comparable